MCID: HYP026
MIFTS: 36

Hypoglycemic Coma malady

Categories: Endocrine diseases, Neuronal diseases

Aliases & Classifications for Hypoglycemic Coma

About this section

Aliases & Descriptions for Hypoglycemic Coma:

Name: Hypoglycemic Coma 10 47 12 65
Hypoglycemic Coma Nos 10
 
Hypoglycaemic Coma 10

Classifications:



External Ids:

Disease Ontology10 DOID:1607
ICD1027 E15
ICD9CM29 251.0
UMLS65 C0020617

Summaries for Hypoglycemic Coma

About this section
MalaCards based summary: Hypoglycemic Coma, also known as hypoglycemic coma nos, is related to postherpetic neuralgia and acyl-coa dehydrogenase, medium chain, deficiency of. An important gene associated with Hypoglycemic Coma is INS (Insulin), and among its related pathways are Cardiac Progenitor Differentiation and Signaling events mediated by TCPTP. Affiliated tissues include bone, kidney and bone marrow, and related mouse phenotypes are liver/biliary system and renal/urinary system.

Related Diseases for Hypoglycemic Coma

About this section

Diseases related to Hypoglycemic Coma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 114)
idRelated DiseaseScoreTop Affiliating Genes
1postherpetic neuralgia30.6POMC, VEGFA
2acyl-coa dehydrogenase, medium chain, deficiency of10.5
3myocardial infarction10.3
4breast cancer10.3
5kawasaki disease10.3
6leukemia10.3
7cervicitis10.3
8thoracic aortic aneurysm10.2IGF2, VEGFA
9hypothyroidism due to deficient transcription factors involved in pituitary development or function10.2IGF2, VEGFA
10fetal methimazole syndrome10.2IGF2, INS
11right bundle branch block10.2HBA2, VEGFA
12restless legs syndrome10.2
13urethritis10.2
14urethral stricture10.2
15endotheliitis10.2
16sella turcica neoplasm10.2INS, POMC
17arteriovenous malformation10.2INS, POMC
18pulmonary embolism10.2INS, POMC
19hemangioma of spleen10.2POMC, VEGFA
20fatal infantile encephalomyopathy10.1IGF2, POMC
21chronic follicular conjunctivitis10.1IGF2, INS
22leptospirosis10.1POMC, VEGFA
23lung cancer10.1
24aplastic anemia10.1
25allergic rhinitis10.1
26galactosemia10.1
27melkersson-rosenthal syndrome10.1
28jervell and lange-nielsen syndrome10.1
29haim-munk syndrome10.1
30aspergillosis10.1
31li-fraumeni syndrome10.1
32pityriasis rubra pilaris10.1
33dermatofibrosarcoma protuberans10.1
34hemochromatosis10.1
35acute myocardial infarction10.1
36bipolar disorder10.1
37breast reconstruction10.1
38hemolytic anemia10.1
39keratoconus10.1
40polycystic ovary syndrome10.1
41spinal cord injury10.1
42segmental dystonia10.1
43oral squamous cell carcinoma10.1
44omphalocele10.1
45asbestosis10.1
46lymphoblastic leukemia10.1
47meningoencephalitis10.1
48sarcoma10.1
49syndactyly10.1
50pyelonephritis10.1

Graphical network of the top 20 diseases related to Hypoglycemic Coma:



Diseases related to hypoglycemic coma

Symptoms for Hypoglycemic Coma

About this section

Drugs & Therapeutics for Hypoglycemic Coma

About this section

Drugs for Hypoglycemic Coma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 26)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Insulin AspartapprovedPhase 2423116094-23-616132418
Synonyms:
(AspB28)-human insulin
1024611-56-0
116094-23-6
139532-40-4
28(sup B)-L-Aspartic acid-insulin (human)
877034-90-7
AspB28-insulin (human)
Aspart
Aspart Insulin
Aspart insulin
B28-Asp-insulin
B28-Aspart-Insulin
INA-X 14
 
INA-X14
Insulin X14
Insulin aspart
Insulin aspart [USAN]
Insulin, Asp(B28)
LS-185932
NovoLog
NovoMix 30
NovoRapid
NovoRapid 30 Mix
Novolog
Novolog Mix 70/30
Novolog mix 70/30
UNII-D933668QVX
2
Etanerceptapproved, investigationalPhase 1, Phase 2383185243-69-0
Synonyms:
185243-69-0
CD120b
D00742
Enbrel
Enbrel (TN)
Enbrel Sureclick
Etanercept
Etanercept (USAN/INN)
 
Etanercept (genetical recombination)
Etanercept (genetical recombination) (JAN)
TNF-R2
Tumor necrosis factor receptor 2
Tumor necrosis factor receptor superfamily member 1B precursor
Tumor necrosis factor receptor type II
etanercept
p75
p80 TNF-alpha receptor
3
EverolimusapprovedPhase 1, Phase 21797159351-69-66442177
Synonyms:
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone
(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy
07741_FLUKA
159351-69-6
40-O-(2-hydroxyethyl)-rapamycin
42-O-(2-Hydroxyethyl)rapamycin
Afinitor
Afinitor Disperz
CERTICAN(R)
CHEMBL1201755
Certican
D02714
DB01590
 
Everolimus
Everolimus (JAN/USAN/INN)
Everolimus [USAN]
LS-143292
MolPort-003-847-342
MolPort-003-925-588
NCGC00167512-01
NVP-RAD-001
RAD 001
RAD-001
RAD-001C
RAD001
RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus
S1120_Selleck
SDZ-RAD
UNII-9HW64Q8G6G
VOTUBIA
Zortress
everolimus
4
Sirolimusapproved, investigationalPhase 1, Phase 2179753123-88-95284616, 6436030, 46835353
Synonyms:
(-)-Rapamycin
(-)-rapamycin
1fkb
1pbk
23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine
23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine
23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29
3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
53123-88-9
A422989, NSC226080
AC-722
AC1L1JH9
AC1L7MJ9
AC1L9ZMV
AY 22989
AY-22989
AY22989
Ambotz53123-88-9
Antibiotic AY 22989
BIDD:PXR0165
Bio1_000293
Bio1_000782
Bio1_001271
Bio2_000375
Bio2_000855
BiomolKI2_000084
C07909
C51H79NO13
CBiol_002007
CCRIS 9024
CHEBI:100923
CHEBI:9168
CHEMBL413
CID10213190
CID10795871
CID11949238
CID11959112
CID313006
CID478951
CID5040
CID5284616
CID5358081
CID5374464
CID5460439
CID5497196
CID5924240
CID6436030
CID6610270
CID6610346
CID6711160
CID6713081
CID9833581
CID9854379
CID9854380
CID9962926
CID9962928
D00753
DB00877
DE-109
DivK1c_006936
 
FT-0082351
HMS2089A21
HSDB 7284
KBio1_001880
KBio2_000410
KBio2_002978
KBio2_005546
KBio3_000779
KBio3_000780
KBioGR_000410
KBioSS_000410
LCP-Siro
LMPK06000003
LS-143290
MLS000028373
MS-R001
MolMap_000043
MolPort-003-959-433
NCGC00021305-05
NCI60_001851
NCIMech_000355
NSC 226080
NSC226080
Perceiva
QTL1_000069
R0395_SIAL
R0395_SIGMA
RAP
RAPA
RPM
Rapammune
Rapamune
Rapamune (TN)
Rapamycin
Rapamycin (TN)
Rapamycin C-7, analog 4
Rapamycin Immunosuppressant Drug
Rapamycin from Streptomyces hygroscopicus
S1039_Selleck
SIIA 9268A
SILA 9268A
SILA9268A
SMP1_000255
SMR000058564
Sirolimus
Sirolimus (RAPAMUNE)
Sirolimus (USAN/INN)
Sirolimus [USAN:BAN:INN]
Sirolimus, Rapamune,Rapamycin
SpecPlus_000840
UNII-W36ZG6FT64
UNM-0000358684
WY-090217
Wy 090217
heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy
nchembio.100-comp4
nchembio.2007.42-comp2
nchembio.79-comp1
nchembio762-comp1
nchembio883-comp3
rapamycin
sirolimus
5
Daclizumabapproved, investigationalPhase 1, Phase 296152923-56-3
Synonyms:
Anti-IL-2
Humanized antiCD25
 
Ig gamma-1 chain C region
Simulect
chimeric mouse-human antiCD25
6
Tacrolimusapproved, investigationalPhase 1, Phase 21023104987-11-3445643, 439492, 445647
Synonyms:
(-)-FK 506
(3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone
104987-11-3
109581-93-3 (Hydrate)
15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone,
3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8S*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5, 19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c] [1,4] oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone
8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN
8-DEETHYL-8-[but-3-enyl]-ascomycin
AC-1182
AC1L1K7H
AC1L97GB
AC1L9IBU
AKOS005145901
Advagraf
Ambap104987-11-3
Ambap5429
BCBcMAP01_000194
BRD-K35452788-001-02-1
BSPBio-001279
BSPBio_001279
Bio-0921
Bio2_000470
Bio2_000950
C01375
C44H69NO10
CCRIS 7124
CHEBI:100924
CHEBI:61049
CHEMBL1200738
CID11158639
CID11556866
CID439492
CID445643
CID5372
CID5472317
CID6426916
CID6436007
CID6473866
CID6536850
CID6610362
CID6912836
CID9832283
CID9853905
CID9918805
CID9940643
CID9963169
CPD-10016
CPD000466356
D08556
DB00864
DivK1c_001040
FK 506
FK-506
FK5
FK506
FR 900506
FR-900506
FR900506
 
FT-0082660
Fk-506
Fujimycin
Graceptor
HMS1362O21
HMS1792O21
HMS1990O21
HMS2051C18
HMS2093M19
HMS503O21
Hecoria
IDI1_001040
IDI1_002225
K506
KBio1_001040
KBio2_000619
KBio2_003187
KBio2_005755
KBio3_001097
KBio3_001098
KBioGR_000619
KBioSS_000619
L 679934
L-679934
LCP-Tacro
LMPK04000003
LS-64247
MLS000759471
MLS001424054
Modigraf
MolPort-003-666-518
NCGC00163470-01
NCGC00163470-02
NCGC00163470-03
NCGC00163470-04
NCGC00179232-01
NChemBio.2007.16-comp1
NINDS_001040
NSC717865
Prograf
Prograf (TN)
Protopic
Protopy
S5003_Selleck
SAM001246677
SMR000466356
Tacarolimus
Tacrolimus
Tacrolimus (INN)
Tacrolimus (Prograf?)
Tacrolimus (anhydrous)
Tacrolimus Hydrate
Tacrolimus anhydrous
Tacrolimus hydrate
Tsukubaenolide
UNII-Y5L2157C4J
nchembio.2007.23-comp2
tacrolimus
tacrolimus hydrate
7
Exenatideapproved, investigationalPhase 1, Phase 2269141758-74-915991534
Synonyms:
141732-76-5
141758-74-9
286014-72-0
335149-21-8
AC 2993
AC 2993 LAR
AC 2993A
AC-2993
AC002993
AC2993
AC2993a
Bydureon
Byetta
 
C074031
CHEBI:490990
CHEMBL414357
Ex4 peptide
Exenatide
Exenatide Synthetic
Exenatide synthetic
Exendin 4
Exendin 4 (Heloderma suspectum)
Exendin-4
Extendin-4
LY2148568
Synthetic exendin-4
UNII-9P1872D4OL
8Hypoglycemic AgentsPhase 2, Phase 14503
9Insulin, Globin ZincPhase 24278
10insulinPhase 24278
11Immunosuppressive AgentsPhase 1, Phase 210422
12Immunologic FactorsPhase 1, Phase 218483
13Peripheral Nervous System AgentsPhase 1, Phase 218510
14Anti-Inflammatory Agents, Non-SteroidalPhase 1, Phase 23549
15IncretinsPhase 1, Phase 21326
16Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 1, Phase 29988
17Anti-Inflammatory AgentsPhase 1, Phase 28478
18Antirheumatic AgentsPhase 1, Phase 28496
19HormonesPhase 1, Phase 211748
20Analgesics, Non-NarcoticPhase 1, Phase 25184
21AnalgesicsPhase 1, Phase 29358
22Hormone AntagonistsPhase 1, Phase 210002
23Gastrointestinal AgentsPhase 1, Phase 26401
24
Zincapproved14777440-66-623994, 32051
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
25
Palmitic Acidexperimental2057-10-3985
Synonyms:
1-Hexyldecanoate
1-Hexyldecanoic Acid
1-Hexyldecanoic acid
1-Pentadecanecarboxylic acid
C16 fatty acid
Cetylic acid
Edenor C16
Emersol 140
Emersol 143
FAT
Glycon P-45
Hexadecanoate
Hexadecanoate (n-C16:0)
Hexadecanoic acid
Hexadecanoic acid palmitic acid
Hexadecoate
Hexadecoic acid
Hexadecylic acid
Hexaectylic acid
Hydrofol
Hydrofol acid 1690
Hystrene 8016
Hystrene 9016
 
Industrene 4516
Kortacid 1698
Loxiol EP 278
Lunac P 95
Lunac P 95KC
Lunac P 98
N-Hexadecanoate
N-Hexadecanoic acid
N-Hexadecoate
N-Hexadecoic acid
PAM
PLM
Palmitate
Palmitic acid
Palmitinate
Palmitinic acid
Palmitinsaeure
Palmitoate
Palmitoic acid
Pentadecanecarboxylate
Pentadecanecarboxylic acid
Prifac 2960
Prifrac 2960
Pristerene 4934
Univol U332
26Glucagon-Like Peptide 1620

Interventional clinical trials:

idNameStatusNCT IDPhase
1Using Glucose Sensors to Prevent HypoglycemiaCompletedNCT00554281Phase 3
2Islet Cell Transplantation Alone and CD34+ Donor Bone Marrow Cell Infusion in Type 1 Diabetes MellitusCompletedNCT00315614Phase 2
3Cardiac Surgery Neuroprotection Study in EldersCompletedNCT01561378Phase 2
4Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free ImmunosuppressionActive, not recruitingNCT00566813Phase 1, Phase 2
5Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free ImmunosuppressionActive, not recruitingNCT00306098Phase 2
6Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney TransplantationActive, not recruitingNCT00315588Phase 2
7Steroid-free and Long-term Calcineurin-free Trial in Islet Cell TransplantationActive, not recruitingNCT00315627Phase 2
8Intracellular Counter-regulatory Mechanisms Following Low Blood GlucoseCompletedNCT01919788
9GLP-1 Analogs for Neuroprotection After Cardiac ArrestActive, not recruitingNCT02442791

Search NIH Clinical Center for Hypoglycemic Coma

Genetic Tests for Hypoglycemic Coma

About this section

Anatomical Context for Hypoglycemic Coma

About this section

MalaCards organs/tissues related to Hypoglycemic Coma:

33
Bone, Kidney, Bone marrow, Myeloid, T cells, Monocytes, Pituitary

Animal Models for Hypoglycemic Coma or affiliated genes

About this section

MGI Mouse Phenotypes related to Hypoglycemic Coma:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053709.0IGF2, INS, POMC, VEGFA
2MP:00053678.8IGF2, INS, POMC, VEGFA
3MP:00053798.4IGF2, INS, POMC, RAPGEF4, VEGFA
4MP:00030128.3IGF2, INS, POMC, RAPGEF4, VEGFA
5MP:00053898.1HBA2, IGF2, INS, NTF3, VEGFA
6MP:00053697.5IGF2, INS, NTF3, RAPGEF4, VEGFA
7MP:00053857.3IGF2, INS, NTF3, POMC, RAPGEF4, VEGFA
8MP:00053767.2IGF2, INS, NTF3, POMC, RAPGEF4, VEGFA

Publications for Hypoglycemic Coma

About this section

Articles related to Hypoglycemic Coma:

(show top 50)    (show all 103)
idTitleAuthorsYear
1
Sos1 Regulates Macrophage Podosome Assembly and Macrophage Invasive Capacity. (26447228)
2015
2
Successful Treatment of Macroglossia Due to Lymphatic Malformation With Sirolimus. (25902840)
2015
3
Hypoglycemia, polycythemia and hyponatremia in a newborn exposed to nebivolol during pregnancy. (25709355)
2015
4
Effects of treatment with a combination of cardiac rehabilitation and bosentan in patients with pulmonary Langerhans cell histiocytosis associated with pulmonary hypertension. (23897898)
2013
5
Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma. (22847610)
2013
6
A comprehensive approach to the segmentation of multichannel three-dimensional MR brain images in multiple sclerosis. (24179773)
2013
7
Chronic hypersensitivity pneumonitis: high resolution computed tomography patterns and pulmonary function indices as prognostic determinants. (22466512)
2012
8
Intraoral endoscopic enucleation of a solitary bone cyst of the mandibular condyle. (22024140)
2012
9
ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. (22134106)
2012
10
Pathology in practice. Proliferative and necrotizing otitis externa. (22916853)
2012
11
Application of the procedural consolidation concept to surgical treatment of children with epidermolysis bullosa: a retrospective analysis. (21853547)
2011
12
Hypermethylation of promoter regions of the APC1A and p16INK4a genes in relation to prognosis and tumor characteristics in cervical cancer patients. (21674126)
2011
13
Common variations in the genes encoding C-reactive protein, tumor necrosis factor-alpha, and interleukin-6, and the risk of clinical diabetes in the Women's Health Initiative Observational Study. (21149504)
2011
14
The Ca2+ channel beta4c subunit interacts with heterochromatin protein 1 via a PXVXL binding motif. (21220418)
2011
15
An evaluation of serum albumin, root caries, and other covariates in Gullah African Americans with type-2 diabetes. (21070320)
2011
16
Nucleolar targeting of coilin is regulated by its hypomethylation state. (20449600)
2010
17
Spinal epidural lipomatosis due to a bronchial ACTH-secreting carcinoid tumour. (20709555)
2010
18
Craving-induced EEG reactivity in smokers: effects of mood induction, nicotine dependence and gender. (19212134)
2008
19
Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. (18606398)
2008
20
Receptor "hijacking" by malignant glioma cells: a tactic for tumor progression. (18433988)
2008
21
Emergency contraception: a review. (18283598)
2008
22
A quantitative regional expression profile of EAAT2 known and novel splice variants reopens the question of aberrant EAAT2 splicing in disease. (17050039)
2007
23
Effect of auricular cartilage graft in the surgical treatment of temporomandibular joint ankylosis: An animal study using sheep. (17236921)
2007
24
Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract. (17245649)
2007
25
HLA-G complexes are observed on the cell surface. (17400056)
2007
26
Mutation R238E in transducin-alpha yields a GTPase and effector-deficient, but not dominant-negative, G-protein alpha-subunit. (16735989)
2006
27
Severe tick-borne encephalitis in Slovenia in the years 2001-2005: time for a mass vaccination campaign? (17186173)
2006
28
Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha-blockers in rheumatoid arthritis: a meta-analysis. (16909270)
2006
29
TBG deficiency: description of two novel mutations associated with complete TBG deficiency and review of the literature. (16947003)
2006
30
Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura. (15996929)
2005
31
Rapamycin: an anti-cancer immunosuppressant? (16039868)
2005
32
Intracellular K+ is required for the inactivation-induced high-affinity binding of cisapride to HERG channels. (15967876)
2005
33
The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity. (14612545)
2003
34
Phosphorylation of CIITA directs its oligomerization, accumulation and increased activity on MHCII promoters. (12374747)
2002
35
Oral administration of freshly expressed juice of Echinacea purpurea herbs fail to stimulate the nonspecific immune response in healthy young men: results of a double-blind, placebo-controlled crossover study. (12218779)
2002
36
ABCA1(Alabama): a novel variant associated with HDL deficiency and premature coronary artery disease. (12204794)
2002
37
Genetic polymorphisms of Rb and susceptibility of esophageal cancer]. (11832063)
2000
38
Allelic variations of the D2 dopamine receptor gene in children with idiopathic short stature. (9929973)
1999
39
Expression of leptin receptor in lung: leptin as a growth factor. (9988112)
1999
40
Fluorescence-activated cell sorter analysis in patients with cutaneous lupus erythematosus. (10376710)
1999
41
Retroperitoneal paragonimiasis: a case of ectopic paragonimiasis presenting as periureteral masses. (10524848)
1999
42
Release factor RF3 abolishes competition between release factor RF1 and ribosome recycling factor (RRF) for a ribosome binding site. (9344747)
1997
43
Placenta growth factor is abundantly expressed in human cervical squamous cell carcinoma. (9443023)
1997
44
Gender identity disorder: a review of the past 10 years. (9204664)
1997
45
Analysis of the allelic polymorphism of four short tandem repeats in a population from the northwestern region of Russia]. (7635321)
1995
46
Chromosome 22 monosomy in a radiation-induced meningioma. (8354634)
1993
47
Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. (8133587)
1993
48
Internal carotid artery occlusion associated with Mycoplasma pneumoniae infection. (1622526)
1992
49
Peutz-Jeghers syndrome with feminizing sertoli cell tumor. (6770991)
1980
50

Variations for Hypoglycemic Coma

About this section

Expression for genes affiliated with Hypoglycemic Coma

About this section
Search GEO for disease gene expression data for Hypoglycemic Coma.

Pathways for genes affiliated with Hypoglycemic Coma

About this section

GO Terms for genes affiliated with Hypoglycemic Coma

About this section

Biological processes related to Hypoglycemic Coma according to GeneCards Suite gene sharing:

(show all 15)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of glycogen biosynthetic processGO:004572510.3IGF2, INS
2wound healingGO:004206010.1IGF2, INS
3positive regulation of protein autophosphorylationGO:00319549.9INS, VEGFA
4positive regulation of protein kinase B signalingGO:00518979.9IGF2, INS
5platelet degranulationGO:00025769.9IGF2, VEGFA
6positive regulation of protein phosphorylationGO:00019349.7IGF2, VEGFA
7activation of protein kinase B activityGO:00321489.7INS, NTF3
8glucose metabolic processGO:00060069.7IGF2, INS
9positive regulation of receptor internalizationGO:00020929.6NTF3, VEGFA
10positive regulation of peptidyl-serine phosphorylationGO:00331389.5NTF3, VEGFA
11positive chemotaxisGO:00509189.4NTF3, VEGFA
12platelet activationGO:00301689.1IGF2, RAPGEF4, VEGFA
13positive regulation of peptidyl-tyrosine phosphorylationGO:00507318.7IGF2, INS, NTF3, VEGFA
14positive regulation of cell migrationGO:00303358.7INS, NTF3, VEGFA
15positive regulation of cell proliferationGO:00082848.6IGF2, INS, NTF3

Sources for Hypoglycemic Coma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet